Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrighton Pier Regulatory News (PIER)

  • There is currently no data for PIER

Total Voting Rights

1 Feb 2018 07:00

RNS Number : 3492D
Brighton Pier Group PLC (The)
01 February 2018
 

1 February 2018

The Brighton Pier Group PLC

("Brighton Pier Group" or the "Company")

 

Total Voting Rights

 

For the purposes of the Financial Conduct Authority's Disclosure, Guidance and Transparency Rules, the directors of the Company advise that as of the date of this notice the total number of ordinary shares of 25p each in issue is 35,664,010 with each share carrying the right to one vote.

There are no ordinary shares held in treasury.

The total number of voting rights in the Company is therefore 35,664,010.

The above figures may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure, Guidance and Transparency Rules. 

Enquiries:

 

The Brighton Pier Group Plc

 

Tel: 020 7376 6300

Luke Johnson, Executive Chairman

Anne Ackord, Chief Executive Officer

John Smith, Chief Financial Officer

Panmure Gordon (UK) Limited (Nominated Adviser and Joint Broker )

Tel: 020 7886 2500

Corporate Finance

Andrew Godber / Atholl Tweedie / Edward Phillips

Corporate Broking

Charles Leigh-Pemberton

Arden Partners plc (Joint Broker)

Tel: 0207 7614 5900

Corporate Finance

John Llewellyn-Lloyd / Benjamin Cryer

Corporate Broking

Jonathan Keeling

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRWGUGUGUPRGPU
Date   Source Headline
2nd May 20257:00 amRNSCancellation - Brighton Pier Group Plc (The)
29th Apr 20252:20 pmRNSHolding(s) in Company
25th Apr 20256:00 pmRNSBrighton Pier Group
23rd Apr 20255:30 pmRNSHolding(s) in Company
22nd Apr 202512:15 pmRNSResult of General Meeting
17th Apr 20258:30 amRNSHolding(s) in Company
14th Apr 20258:26 amRNSHolding(s) in Company
14th Apr 20258:25 amRNSHolding(s) in Company
2nd Apr 20257:00 amRNSProposed Cancellation
31st Jan 20257:52 amRNSHolding(s) in Company
18th Oct 202410:32 amRNSBlock listing Interim Review
30th Sep 20247:00 amRNSInterim Results
5th Aug 202412:35 pmRNSDirector/PDMR Shareholding
26th Jul 20247:00 amRNSTrading Update
13th Jun 20247:00 amRNSResult of AGM
31st May 20247:00 amRNSAppointment of Non-Executive Director
29th May 202412:50 pmRNSDirector/PDMR Shareholding
21st May 20247:00 amRNSPublication of Annual Report
8th May 20247:00 amRNSFinal Results
25th Apr 20247:00 amRNSNotice of results & AGM
22nd Apr 20249:40 amRNSBlock listing Interim Review
4th Mar 20245:29 pmRNSHolding(s) in Company
13th Dec 20237:00 amRNSChange of Name of Nomad and Broker
11th Oct 20235:38 pmRNSBlock listing Interim Review
25th Sep 20237:00 amRNSInterim Results
25th Jul 20237:00 amRNSTrading Statement
13th Jun 20237:00 amRNSResult of AGM
18th May 20234:03 pmRNSPublication of Annual Report
26th Apr 202312:00 pmRNSAnnual Report update
24th Apr 20237:00 amRNSFinal Results
15th Feb 20237:00 amRNSTrading Statement
7th Dec 202211:11 amRNSResult of AGM
22nd Nov 202212:49 pmRNSDeath of Director
16th Nov 202212:39 pmRNSNotice of AGM
11th Oct 202211:27 amRNSBlock listing Interim Review
26th Sep 202211:06 amRNSSecond Price Monitoring Extn
26th Sep 202211:00 amRNSPrice Monitoring Extension
26th Sep 20227:00 amRNSHalf-year Report
26th Jul 20227:00 amRNSTrading Statement
20th Jun 20227:00 amRNSChange of Accounting Date
12th Apr 20229:15 amRNSBlock listing Interim Review
28th Mar 20227:00 amRNSHalf-year Report
23rd Mar 20227:00 amRNSNotice of Results
16th Feb 20227:00 amRNSNotice of Investor Presentation
17th Jan 20227:00 amRNSTrading Update
15th Dec 20214:33 pmRNSResult of AGM
23rd Nov 20211:20 pmRNSPublication of Annual Report
1st Nov 20217:00 amRNSFinal Results
12th Oct 20217:00 amRNSNotice of Results and AGM
12th Oct 20217:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.